imiquimod has been researched along with krn 7000 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giese, T; Kaufmann, SH; Raftery, MJ; Schaible, UE; Schönrich, G; Winau, F | 1 |
| Hennessy, T; Hook, S; McBurney, WT; Myschik, J; Rades, T | 1 |
2 other study(ies) available for imiquimod and krn 7000
| Article | Year |
|---|---|
Viral danger signals control CD1d de novo synthesis and NKT cell activation.
Topics: Aminoquinolines; Antigen Presentation; Antigens, CD1; Antigens, CD1d; Cell Line; Cell Membrane; Coculture Techniques; Cytomegalovirus; Dendritic Cells; Galactosylceramides; Gene Expression; Herpesvirus 1, Human; Humans; Imiquimod; Interferon Inducers; Interferon Type I; Interferon-alpha; Interferon-gamma; Intracellular Space; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocyte Activation; Poly I-C; Toll-Like Receptors; Virus Diseases | 2008 |
Immunogenicity of lipid sustained release implants containing imiquimod, alpha-galactosylceramide, or Quil-A.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antineoplastic Agents; CD8-Positive T-Lymphocytes; Delayed-Action Preparations; Drug Carriers; Drug Implants; Epitopes; Flow Cytometry; Galactosylceramides; Imiquimod; Immunization; Immunoglobulin G; Lipids; Mice; Mice, Inbred C57BL; Microscopy, Electron, Transmission; Organisms, Genetically Modified; Ovalbumin; Quillaja Saponins; Saponins; Vaccines | 2008 |